Studies have shown that SOX1 can inhibit the occurrence and development of HCC, esophageal cancer, nasopharyngeal carcinoma, lung cancer, and cervical cancer [7, 12–14]; however, its role in CCA has not been reported. Here, SOX1 is linked to cholangiocarcinoma.